Allegro Gets Another $5.4M

Xconomy Boston — 

Maynard, MA-based Allegro Diagnostics said today that it has plumped up its Series A financing by another $5.4 million. The money comes from existing investors Kodiak Venture Partners and Catalyst Health Ventures. Allegro is developing a diagnostic platform for lung cancer that uses gene expression of normal epithelial cells in the respiratory tract to detect early signs of the disease.